Abstract
Vulvovaginal atrophy is a common condition associated with decreased estrogenization of the vaginal tissue. Symptoms include vaginal dryness, irritation, itching, soreness, burning, dyspareunia, discharge, urinary frequency, and urgency. It can occur at any time in a woman's life cycle, although more commonly in the postmenopausal phase, during which the prevalence is approximately 50%. Despite the high prevalence and the substantial effect on quality of life, vulvovaginal atrophy often remains underreported and undertreated. This article aims to review the physiology, clinical presentation, assessment, and current recommendations for treatment, including aspects of effectiveness and safety of local vaginal estrogen therapies.
| Original language | English |
|---|---|
| Pages (from-to) | 476-491 |
| Number of pages | 16 |
| Journal | Clinical Obstetrics and Gynecology |
| Volume | 58 |
| Issue number | 3 |
| DOIs | |
| State | Published - 5 Aug 2015 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
Keywords
- atrophy
- low estrogen
- vagina
- vulva
Fingerprint
Dive into the research topics of 'Vulvar and Vaginal Atrophy: Physiology, Clinical Presentation, and Treatment Considerations'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver